Literature DB >> 11096137

Renal expression of aminopeptidase A in rats with two-kidney, one-clip hypertension.

G Wolf1, U Wenzel, K J Assmann, R A Stahl.   

Abstract

BACKGROUND: Angiotensin II (ANG II) is a major factor involved in the progression of chronic renal disease. Although the generation of this vasoactive peptide has been investigated in great detail, only a few studies have hitherto addressed the metabolism of ANG II into fragments such as angiotensin III and IV (ANG III, IV) which may exert physiological effects independent of ANG II. Aminopeptidase A (APA) is the major enzyme degrading ANG II. The aim of the current study was to evaluate glomerular APA expression in rats with two-kidney, one-clip hypertension.
METHODS: The left renal artery was restricted with a 0.2-mm silver clip. Kidneys were harvested 1 and 4 weeks after surgery. APA enzyme and protein expression was evaluated in kidney sections. Total APA enzyme activity and mRNA expression was assessed in isolated glomeruli. Degradation of exogenous ANG II by isolated glomeruli was measured with reverse-phase high-performance liquid chromatography.
RESULTS: APA enzyme activity, protein, and mRNA expression were stimulated in the clipped kidney 1 week after surgery compared with the contralateral kidney or normal controls. In contrast, 4 weeks after clipping APA activity and expression was higher in the contralateral kidney. In parallel to these findings, degradation of ANG II was greatest in isolated glomeruli obtained from the clipped kidney after 1 week. However, preparations from the contralateral kidney 4 weeks after surgery were more active in the metabolism of exogenous ANG II.
CONCLUSION: The present study provides evidence that APA is complexly regulated in in vivo situations with an activated local renin-ANG II system. ANG II appears to play a direct role in this regulation. However, since conversion of ANG II to ANG III by APA is the initial step leading to the formation of ANG IV which may exert detrimental effects not mediated through classical ANG II receptors, a local increase in APA activity may contribute to the progression of chronic renal disease even during complete AT(1)-receptor blockade.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096137     DOI: 10.1093/ndt/15.12.1935

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

Review 1.  The importance of the intrarenal renin-angiotensin system.

Authors:  Juan Carlos Q Velez
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-09

2.  Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.

Authors:  Mahmoud S Alghamri; Mariana Morris; J Gary Meszaros; Khalid M Elased; Nadja Grobe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

3.  Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors.

Authors:  Megumi Kanasaki; Takako Nagai; Munehiro Kitada; Daisuke Koya; Keizo Kanasaki
Journal:  Fibrogenesis Tissue Repair       Date:  2011-11-30

Review 4.  Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity.

Authors:  Maryam Eskandari Mehrabadi; Roohullah Hemmati; Amin Tashakor; Ahmad Homaei; Masoumeh Yousefzadeh; Karim Hemati; Saman Hosseinkhani
Journal:  Biomed Pharmacother       Date:  2021-02-05       Impact factor: 7.419

Review 5.  New insights into the importance of aminopeptidase A in hypertension.

Authors:  Shigehiko Mizutani; Masakazu Ishii; Akira Hattori; Seiji Nomura; Yasushi Numaguchi; Masafumi Tsujimoto; Hiroshi Kobayshi; Toyoaki Murohara; John W Wright
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

6.  Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury.

Authors:  Jean-Christophe Wyss; Rajesh Kumar; Josip Mikulic; Manfred Schneider; Jean-Luc Mary; Johannes D Aebi; Lucienne Juillerat-Jeanneret; Dela Golshayan
Journal:  Front Pharmacol       Date:  2019-11-08       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.